Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Rebecca S. Pettit, Coleen M. Sakon, Kaitlyn E. Kinney, Cynthia Brown, Katherine A. Gallaway, Sarah A. Wagner, Emma M. Tillman |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Prevalence of cannabidiol use in persons with cystic fibrosis
by: Emma M. Tillman, et al.
Published: (2024)
by: Emma M. Tillman, et al.
Published: (2024)
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
by: Emma M. Tillman, et al.
Published: (2025)
by: Emma M. Tillman, et al.
Published: (2025)
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
by: Tyler Shugg, et al.
Published: (2025)
by: Tyler Shugg, et al.
Published: (2025)
Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
by: Chelsea Flora, et al.
Published: (2026)
by: Chelsea Flora, et al.
Published: (2026)
Real World Adverse Effects of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis Ages 6–11 Years
by: Rebecca S. Pettit, et al.
Published: (2025)
by: Rebecca S. Pettit, et al.
Published: (2025)
Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis
by: Rebecca S. Pettit, et al.
Published: (2025)
by: Rebecca S. Pettit, et al.
Published: (2025)
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
by: Charissa W. Kam, et al.
Published: (2024)
by: Charissa W. Kam, et al.
Published: (2024)
Facilitators and Barriers to Increasing Equity in Cystic Fibrosis Newborn Screening Algorithms
by: Kellyn Madden, et al.
Published: (2024)
by: Kellyn Madden, et al.
Published: (2024)
Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
by: Rebecca Gallardo, et al.
Published: (2026)
by: Rebecca Gallardo, et al.
Published: (2026)
Stakeholder Priorities for Cystic Fibrosis Mental Health Research: A Community and Provider Survey
by: Anna M. Georgiopoulos, et al.
Published: (2026)
by: Anna M. Georgiopoulos, et al.
Published: (2026)
The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
by: Rebecca J. Vitale, et al.
Published: (2026)
by: Rebecca J. Vitale, et al.
Published: (2026)
Roadmap to Global Cystic Fibrosis Care
by: Samya Z. Nasr, et al.
Published: (2025)
by: Samya Z. Nasr, et al.
Published: (2025)
Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
by: Brittany A. Wright, et al.
Published: (2025)
by: Brittany A. Wright, et al.
Published: (2025)
Molecular Methods to Detect and Quantify Fungal Communities in Cystic Fibrosis Airway Specimens
by: Matthew K. Fought, et al.
Published: (2026)
by: Matthew K. Fought, et al.
Published: (2026)
Pathophysiology of Cystic Fibrosis Liver Disease
by: Vania L. Kasper, et al.
Published: (2024)
by: Vania L. Kasper, et al.
Published: (2024)
Cystic Fibrosis Year in Review 2024
by: Adrienne P. Savant
Published: (2025)
by: Adrienne P. Savant
Published: (2025)
Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
by: Suzanne Kroes, et al.
Published: (2026)
by: Suzanne Kroes, et al.
Published: (2026)
Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
by: Jeremy P. Tervo, et al.
Published: (2025)
by: Jeremy P. Tervo, et al.
Published: (2025)
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
by: Leslie Huang, et al.
Published: (2025)
by: Leslie Huang, et al.
Published: (2025)
Expanding Cystic Fibrosis Registries to the Rest of the World
by: Lutz Naehrlich
Published: (2026)
by: Lutz Naehrlich
Published: (2026)
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
by: Gabriela R. Oates, et al.
Published: (2025)
by: Gabriela R. Oates, et al.
Published: (2025)
A Dose of Hope: Successful Tobramycin Desensitization in Pediatric Cystic Fibrosis
by: Isabel G. Wedig, et al.
Published: (2025)
by: Isabel G. Wedig, et al.
Published: (2025)
Preliminary Psychometric Characteristics of the Cystic Fibrosis Coping Self‐Efficacy (CF‐CSE) Scale
by: Deborah Friedman, et al.
Published: (2025)
by: Deborah Friedman, et al.
Published: (2025)
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025)
by: Cindy L. Williams, et al.
Published: (2025)
Disparities in Access to Cystic Fibrosis Therapy Across Countries
by: Bulent Karadag
Published: (2026)
by: Bulent Karadag
Published: (2026)
“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)
Objectively Monitored Sleep in School‐Age Children With Cystic Fibrosis and Their Parents
by: Andrea L. Fidler, et al.
Published: (2025)
by: Andrea L. Fidler, et al.
Published: (2025)
Risk Factors and Outcomes of Pulmonary Exacerbations in Infants and Young Children With Cystic Fibrosis
by: Aoife Corcoran, et al.
Published: (2025)
by: Aoife Corcoran, et al.
Published: (2025)
Advancing Mental Healthcare for Individuals With Cystic Fibrosis in Low‐ and Middle‐Income Countries
by: Alexandra L. Quittner, et al.
Published: (2026)
by: Alexandra L. Quittner, et al.
Published: (2026)
Body Image Perceptions and Elexacaftor/Tezacaftor/Ivacaftor (ETI) Use in Adolescents and Young Adults Living With Cystic Fibrosis
by: Emma R. Lyons, et al.
Published: (2025)
by: Emma R. Lyons, et al.
Published: (2025)
Transforming Care in Cystic Fibrosis: The Long‐Term Impact of Quality Improvement Projects on Clinical Outcomes
by: S. Karabulut, et al.
Published: (2026)
by: S. Karabulut, et al.
Published: (2026)
Development of a Simplified Arabic Questionnaire of Health‐Related Quality of Life for Children With Cystic Fibrosis
by: Heba A. Ali, et al.
Published: (2025)
by: Heba A. Ali, et al.
Published: (2025)
Induced Sputum: A Valuable Tool for Assessing Cellular and Microbiological Characteristics in Cystic Fibrosis Expectorating Teenagers
by: M. Guedes, et al.
Published: (2025)
by: M. Guedes, et al.
Published: (2025)
Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
by: Laurie P. Murray, et al.
Published: (2025)
by: Laurie P. Murray, et al.
Published: (2025)
E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
by: Maryam Sahibqran, et al.
Published: (2024)
by: Maryam Sahibqran, et al.
Published: (2024)
Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
by: Sean Coyne, et al.
Published: (2024)
by: Sean Coyne, et al.
Published: (2024)
Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real‐Life Study
by: A. M. Zwitserloot, et al.
Published: (2025)
by: A. M. Zwitserloot, et al.
Published: (2025)
“It's Like You're Feeding Your Child Twice”: Barriers and Facilitators to Human Milk Feeding Children With Cystic Fibrosis
by: Adrianne Colborg, et al.
Published: (2025)
by: Adrianne Colborg, et al.
Published: (2025)
Qualitative Experiences and Depression/Anxiety Scores in Parents of Children With Cystic Fibrosis Transmembrane Conductance Regulator Related Metabolic Syndrome
by: Lynne Carty, et al.
Published: (2025)
by: Lynne Carty, et al.
Published: (2025)
Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
by: Elizabeth Clarke, et al.
Published: (2024)
by: Elizabeth Clarke, et al.
Published: (2024)
Similar Items
-
Prevalence of cannabidiol use in persons with cystic fibrosis
by: Emma M. Tillman, et al.
Published: (2024) -
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
by: Emma M. Tillman, et al.
Published: (2025) -
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
by: Tyler Shugg, et al.
Published: (2025) -
Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
by: Chelsea Flora, et al.
Published: (2026) -
Real World Adverse Effects of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis Ages 6–11 Years
by: Rebecca S. Pettit, et al.
Published: (2025)